Efficacy of a Recombinant Humanized Anti-IL-6 Receptor Monoclonal Antibody Compared to Hemoperfusion in Severe COVID-19 Pneumonia: Ambispective Cohort Study

被引：0
|
作者：
Thammavaranucupt, Kanin [1 ]
Jayanama, Kulapong [1 ]
Spanuchart, Ittikorn [2 ]
机构：
[1] Chakri Naruebodin Med Inst, Bang Phli, Thailand
[2] Mahidol Univ, Fac Med, Ramathibodi Hosp, Bangkok, Thailand
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
FR-PO016
引用
收藏
页码：330 / 330
页数：1
相关论文
共 50 条
  • [21] Anti-IL-17 monoclonal antibodies in hospitalized patients with severe COVID-19: A pilot study
    Avdeev, Sergey N.
    V. Trushenko, Natalia
    Tsareva, Natalia A.
    Yaroshetskiy, Andrey I.
    Merzhoeva, Zamira M.
    Nuralieva, Galia S.
    V. Nekludova, Galina
    Chikina, Svetlana Yu.
    Gneusheva, Tatiana Yu.
    Suvorova, Olga A.
    Shmidt, Anna E.
    CYTOKINE, 2021, 146
  • [22] EFFICACY OF BARICITINIB IN PATIENTS TREATED WITH CORTICOSTEROIDS FOR SEVERE COVID-19 PNEUMONIA: A RETROSPECTIVE OBSERVATIONAL COHORT STUDY
    Tay, K. H.
    Sim, L. H. Benedict
    Chidambaram, S. K.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S96 - S96
  • [23] Long-term treatment of systemic onset juvenile idiopathic arthritis (SO-JIA) with humanized anti-IL-6 receptor monoclonal antibody, tocilizumab (Actemra®)
    Yokota, S
    Miyamae, T
    Kurosawa, R
    Ozawa, R
    Imagawa, T
    Mori, M
    Nishimoto, N
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S725 - S725
  • [24] The IL-6 hypothesis in COVID-19: A phase 2, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of free IL-6 sequestration by the monoclonal antibody sirukumab in severe and critical COVID-19
    Gottlieb, Robert L.
    Clement, Meredith
    Cook, Paul
    Deveikis, Audra
    Foong, Kap Sum
    Robinson, Philip
    Slim, Jihad
    Spak, Cedric W.
    Buelens, Annemie
    Callewaert, Katleen
    De Meyer, Sandra
    Mo, Wai Ling
    Verbrugge, Inge
    Van Wesenbeeck, Liesbeth
    Zhuang, Yanli
    Chien, Jason W.
    Opsomer, Magda
    Van Landuyt, Erika
    JOURNAL OF INFECTION, 2024, 89 (04)
  • [25] EFFICACY OF LEVILIMAB, NOVEL MONOCLONAL ANTI-IL-6 RECEPTOR ANTIBODY, IN COMBINATION WITH METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: 1-YEAR RESULTS OF PHASE 2 AURORA STUDY
    Mazurov, V.
    Zotkin, E.
    Ilivanova, E.
    Kropotina, T.
    Plaksina, T.
    Nesmeyanova, O.
    Soroka, N.
    Kundzer, A.
    Lutskii, A.
    Dokukina, E.
    Eremeeva, A.
    Zinkina-Orihan, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 633 - 634
  • [26] Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study
    Nishimoto, N.
    Miyasaka, N.
    Yamamoto, K.
    Kawai, S.
    Takeuchi, T.
    Azuma, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (10) : 1580 - 1584
  • [27] Tocilizumab (humanized anti IL-6 receptor monoclonal antibody) in patients with systemic lupus erythematosus (SLE): Safety, tolerability and preliminary efficacy.
    Illei, Gabor G.
    Yarboro, Cheryl
    Shirota, Yuko
    Tackey, Edward
    Lapteva, Larissa
    Fleisher, Thomas
    Balow, James
    Lipsky, Peter
    ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 4043 - 4043
  • [28] ANTI-IL-6 RECEPTOR ANTIBODY AMELIORATES DISEASE ACTIVITY OF RHEUMATOID ARTHRITIS PATIENTS WITH KNEE JOINT INVOLVEMENT -ANSWER COHORT STUDY-
    Maeda, Y.
    Hirano, T.
    Hara, R.
    Ebina, K.
    Hashimoto, M.
    Yamamoto, W.
    Murakami, K.
    Kotani, T.
    Hata, K.
    Son, Y.
    Amuro, H.
    Onishi, A.
    Sadao, J.
    Katayama, M.
    Kumanogoh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 298 - 299
  • [29] A Phase IIb Study Of The Efficacy and Safety Of Subcutaneous Clazakizumab (anti-IL-6 monoclonal antibody) With Or Without Methotrexate In Adults With Moderate-To-Severe Active Rheumatoid Arthritis and An Inadequate Response To Methotrexate
    Weinblatt, M.
    Mease, P.
    Mysler, E.
    Takeuchi, T.
    Drescher, E.
    Berman, A.
    Zilberstein, M.
    Xing, J.
    Emery, P.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S735 - S736
  • [30] A PHASE IIB STUDY OF THE EFFICACY AND SAFETY OF SUBCUTANEOUS CLAZAKIZUMAB (ANTI-IL-6 MONOCLONAL ANTIBODY) WITH OR WITHOUT METHOTREXATE IN ADULTS WITH MODERATE-TO-SEVERE ACTIVE RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE
    Weinblatt, M.
    Mease, P.
    Mysler, E.
    Takeuchi, T.
    Drescher, E.
    Berman, A.
    Zilberstein, M.
    Xing, J.
    Emery, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 680 - 681
12345